CVRx, Inc. (CVRX)
NASDAQ: CVRX · Real-Time Price · USD
1.410
-0.015 (-1.05%)
Oct 30, 2026, 4:00 PM EDT - Market closed
CVRx, Inc. Revenue
CVRx, Inc. had revenue of $15.71M in the quarter ending June 30, 2026, with 15.57% growth. This brings the company's total for the last twelve months to $61.19M, up 11.96% year-over-year. In the year 2025, CVRx, Inc. had annual revenue of $56.65M with 10.45% growth. That makes CVRx, Inc. the 26,447th largest company in the world by revenue and 3,629th in the United States.
Revenue (ttm)
$61.19M
Revenue Growth
+11.96%
P/S Ratio
0.61
Revenue / Employee
$274,386
Employees
223
Market Cap
37.56M
Revenue by Geography
- United States 51.88M 91.6%
- Europe 4.77M 8.4%
Fiscal year ended Dec 31, 2025 See the full CVRx, Inc. breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 56.65M | 5.36M | 10.45% |
| Dec 31, 2024 | 51.29M | 12.00M | 30.53% |
| Dec 31, 2023 | 39.30M | 16.83M | 74.89% |
| Dec 31, 2022 | 22.47M | 9.43M | 72.36% |
| Dec 31, 2021 | 13.04M | 6.98M | 115.36% |
| Dec 31, 2020 | 6.05M | -204.00K | -3.26% |
| Dec 31, 2019 | 6.26M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Nortech Systems | 124.65M |
| Xtant Medical Holdings | 109.53M |
| TELA Bio | 79.91M |
| SANUWAVE Health | 44.02M |
| Myomo | 43.26M |
| Rapid Micro Biosystems | 35.18M |
| QT Imaging Holdings | 26.43M |
| Sensus Healthcare | 17.51M |
CVRX News
- 9 days ago - CVRx to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call on November 5, 2026 - GlobeNewsWire
- 4 weeks ago - CVRx Announces Late-Breaking Data and New Clinical Evidence on Barostim at the HFSA Annual Scientific Meeting 2026 - GlobeNewsWire
- 5 weeks ago - CVRx appoints John Landry as CFO - TheFly
- 5 weeks ago - CVRx Appoints John Landry as Chief Financial Officer - GlobeNewsWire
- 2 months ago - CVRx Responds to Letter from Pointillist Family Office - GlobeNewsWire
- 2 months ago - CVRx announces Devoted Health Medicare Advantage coverage policy for Barostim - TheFly
- 2 months ago - Jorey Chernett urges CVRx board to commence formal sales process - TheFly
- 2 months ago - Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer - PRNewsWire